E2006
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Metabolism and Excretion
Conditions
Metabolism and Excretion
Trial Timeline
Feb 1, 2014 → May 1, 2014
NCT ID
NCT02046213About E2006
E2006 is a phase 1 stage product being developed by Eisai for Metabolism and Excretion. The current trial status is completed. This product is registered under clinical trial identifier NCT02046213. Target conditions include Metabolism and Excretion.
What happened to similar drugs?
5 of 20 similar drugs in Metabolism and Excretion were approved
Approved (5) Terminated (2) Active (15)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02089412 | Phase 1 | Completed |
| NCT02046213 | Phase 1 | Completed |
| NCT01673880 | Phase 1 | Completed |
Competing Products
20 competing products in Metabolism and Excretion